1 / 29

Dr Sila Deb DC, Child Health Ministry of Health and Family Welfare

Reporting, Monitoring and Review mechanism for Anemia Mukt Bharat. Dr Sila Deb DC, Child Health Ministry of Health and Family Welfare. Presentation outlines. Monitoring domains Digitalized monitoring process for AMB - HMIS data reporting process

genef
Download Presentation

Dr Sila Deb DC, Child Health Ministry of Health and Family Welfare

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Reporting, Monitoring and Review mechanism forAnemia Mukt Bharat Dr Sila Deb DC, Child Health Ministry of Health and Family Welfare

  2. Presentation outlines • Monitoring domains • Digitalized monitoring process for AMB -HMIS data reporting process - Quarterly Progress Report (QPR) - Key Performance Indicators (KPIs) • Strengthening existing review mechanisms for AMB • AMB monitoring under PoshanAbhiyaan

  3. Robust reporting, monitoring and review mechanism for effective implementation and success of AMB Time-bound reporting, monitoring and review mechanism Accuracy and completeness of data reporting for effective AMB strategy implementation

  4. Monitoring Domains

  5. Digitalised Monitoring Process for AMB • 26 existing HMIS indicators pertaining to anemia are identified to capture data for Quarterly AMB Performance Report Card • 12 new indicators proposed to be included in HMIS • 6 Key Performance Indicators (KPI) for Score Card (generated by Dashboard) • Awards for best 3 performing States – annually – Score Card based ranking • No manual reporting for Monthly Progress Report (e.g. WIFS MPR)

  6. HMIS data elements identified for AMB Data elements for IFA supplementation to children and adoloscents

  7. HMIS data elements identified for AMB Data elements related to Pregnant Women

  8. HMIS data elements identified for AMB Data elements related to stock status

  9. List of New Indicators Proposed in HMIS for AMB

  10. Current Issues in HMIS Data Reporting

  11. Challenges in Data reporting on HMIS • Huge quantity of IFA supplements lying unusable in State/ UT stores • HMIS proper data entry and validation of data is imperative for quality data reporting Letter from JS (RCH)

  12. Field validation of AMB data during regular field visits by AMB nodal persons • AMB nodal persons to develop complete understanding of HMIS data elements used for AMB QPR including the source of data • During field visits HMIS data can be validated with appropriate data source available in field

  13. Examples

  14. HMIS : 9.9 Children (6-59 months) provided 8-10 doses (1ml) of IFA syrup (Bi weekly) • Definition: Total number of children, aged 6-59 months, who were given 8-10 doses of IFA syrup during the reporting month. • Guideline: As per national guidelines, children aged 6-59 months should be given one ml of IFA syrup containing 20 mg of elemental iron and 100 mcg of folic acid biweekly for 100 doses in a year. Those children who were given biweekly dose of IFA syrup for all weeks in the reporting month should be reported. • Source: RCH Register Data Collection Formats: SC/PHC

  15. HMIS 1.2.4:Number of mothers provided full course of 180 IFA tablets after delivery • Definition: Total number of mothers who were given 180 IFA tablets (equivalent to 60 mg of elemental iron and 0.5 mg of folic acid per tablet daily) during the reporting month. • Guideline: The number of mothers who were given 180 IFA tablets are to be reported and NOT the number of IFAtablets. If the number of IFA tablets given to a mother is less than 180, then she should not be reported till she is given 180th tablet. If more than 180 IFA tablets are given to any mother, she should be counted when she had received 180 IFA tablets and should not be counted for extra tablets given to her. • Any person other than woman (who has recently delivered) given IFA tablets should not be counted here. • Data Source –Pregnancy Register/Post natal Register Formats: SC/PHC/CHC/SDH/DH

  16. Fixation of Denominator for Target based monitoring • State/UT-wise as well as district-wise targets are to be fixed before hand for monitoring coverage of each beneficiary age-group • Targets will be updated annually as per the target beneficiary numbers provided by States/UTs

  17. Annual Target Fixation for Reporting under AMB • Fixation of Service denominator: • By the district - district-wise targets (census) for the beneficiary groups • Validation of target– by WCD (Out-of-School) and Dept of Education • Data flow for denominator- from district - to State - to MoHFW –at the beginning of FY (in PIP) • Annual Drug Requirement: • IFA Syrup • IFA Tablets – Red, Blue, Pink

  18. Quarterly Progress Report (QPR) calculation

  19. Data monitoring and review for AMB The process flow: Informed decision for necessary action to strengthen AMB strategies HMIS reporting of data elements for AMB (Anemia status for PW, IFA supplementation and IFA stock status) Review of Key Performance Indicators- Score Card generation Data pulled to AMB dashboard Quarterly Progress Report QPR AMB Dashboard

  20. Key Performance Indicators of AMB • The quarterly report card will be prepared using data reported for the HMIS data elements for AMB • The report card will assess the progress as the percentage coverage against eligible denominators and performance will be monitored based on the coverage review Out of the identified indicators of the quarterly report card, Key Performance Indicators (KPIs) are identified in order to monitor and rank the States and districts based on their performance on a quarterly basis

  21. Key performance indicators • Key performance indicators for AMB • Percentage of children 6-59 months who received at least 8 doses of IFA syrup (HMIS 9.9) • Percentage of school children 5-9 years who received at least 4 pink IFA tablets (HMIS 23.1) • Percentage of school-going adolescents 10-19 years (girls and boys), eligible under RKSK programme, whoreceived at least 4 blue IFA tablet (HMIS 22.1.1) • Percentage of women of reproductive age 20-24 years, eligible under Mission ParivarVikas, who received at least 4red IFA tablet (will be reportedlater) • Percentage of eligible pregnant women who received at least 180 IFA tablets during antenatal contact point (HMIS1.2.4) • Percentage of States/districts with available of adequate stocks of IFA for all age groups (dash board)

  22. Monitoring of IEC/ BCC activities for AMB • AMB nodal officers to carry out periodic monitoring of budget utilization for IEC / BCC activities for AMB activities Compilation of Key IEC/ BCC activities undertaken for AMB Total budget available for all IEC/ BCC activities for AMB in FY Total budget utilized for all IEC/ BCC activities for AMB in FY Analysis of IEC budget utilization

  23. Implemenation Research by National Centre of Excellence and Advanced Research (NCEAR) • The National Centre of Excellence and Advanced Research on Anemia Control (NCEAR-A) will support MoHFW in monitoring through annual rapid assessments of the strategy at the field level • Implemenation research to understand community uptake of interventions under AMB

  24. Monitoring of Non nutritional causes of Anemia • AMB strategies include intensifying awareness, screening and treatment of non-nutritional causes of anemia in endemic pockets, with special focus on malaria, fluorosis and hemoglobinopathies • State / district nodal person for AMB to coordinate with the NVBDCP, NPPCF officials and officials in-charge of management of blood disorder (hemo-globinopathies) for status of malaria and fluorosis prevention and management of hemo-globinopathy cases • AMB unit at National level carry out monitoring for status of implemenation of programmes related to non nutritional causes of anemia Note: In AMB guidelines Annexure 5 list of States / Districts under National Programme for Prevention and Control of Fluorosis (NPPCF) has been provided

  25. Existing review mechanisms to be geared up for AMB review • The existing review mechanisms at district/state/national levels through common review missions, integrated joint monitoring visits, quarterly/biannual reviews at District Magistrate (DM)/ Mission Director (MD) level should integrate the KPIs for monitoring the progress of implementation of Anemia Mukt Bharat

  26. Review under POSHAN Abhiyaan • Specific targets for anaemia reduction has been set under PoshanAbhiyaan: • Reduce anaemia among young children (6-59 months), adolescent girls and young women in the age group 15-49 years by 9%, @ 3% per annum – by 2020 • AMB performance to be reported in the six monthly PoshanAbhiyaan review report submitted by MoHFW as a part of periodic review by NITI Aayog Review mechanisms envisaged under the POSHAN Abhiyaan should also be effectively utilized for reviewing the implementation of Anemia Mukt Bharat strategy

  27. Six institutional mechanisms

  28. AMB Dashboard National Coordinator State Focal Point

  29. THANK YOU

More Related